je.st
news
Ligand Signs License Agreement With Sermonix For Lasofoxifene
2015-02-04 06:55:23| drugdiscoveryonline Home Page
Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Sermonix Pharmaceuticals LLC for the development and commercialization of oral lasofoxifene in the United States and additional territories
Tags: agreement
license
signs
license agreement
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||